Skip to main content
ALKSHealthcare

Alkermes plc (ALKS) Insider Trading

In the last 90 days, 4 Alkermes plc (ALKS) insiders reported no open-market purchases and 7 sales totaling $3,752,026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 2, 2026David Joseph GaffinEVP, CLO, Alkermes, Inc.Sale2,034$41.03$83,455
Sep 3, 2026David Joseph GaffinEVP, CLO, Alkermes, Inc.Sale2,034$48.01$97,652
Sep 1, 2026Craig C. HopkinsonEVP R&D, Chief Medical OfficerSale9,000$46.99$422,874
Aug 17, 2026Christian Todd NicholsSVP, Chief Commercial OfficerSale7,576$49.23$372,937
Aug 3, 2026nancy lynn Md snydermanCorporate insiderSale44,472$50.35$2,239,076
Aug 3, 2026Craig C. HopkinsonEVP R&D, Chief Medical OfficerSale9,000$48.58$437,220
Aug 3, 2026David Joseph GaffinEVP, CLO, Alkermes, Inc.Sale2,034$48.58$98,812
Jul 6, 2026David Joseph GaffinEVP, CLO, Alkermes, Inc.Sale2,034$54.03$109,897
Jul 1, 2026Craig C. HopkinsonEVP R&D, Chief Medical OfficerSale9,000$51.51$463,621
Jun 12, 2026Christopher I WrightCorporate insiderSale2,000$45.10$90,200

Common questions

ALKS insider trading FAQ

Are ALKS insiders buying or selling?
Over the last 90 days, ALKS insiders were net sellers, reporting $0.00 of open-market purchases and $3,752,026 of sales.
When was the last ALKS insider purchase?
No open-market insider purchase of Alkermes plc stock was reported in the last 90 days.
Where does ALKS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Alkermes plc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.